Broadwood boosts STAAR Surgical (STAA) stake with 670K-share open-market buys

Rhea-AI Filing Summary

Broadwood Partners, L.P., a more-than-10% owner and director affiliate of STAAR Surgical, reported a series of open-market purchases of Common Stock. Between March 11 and March 13, Broadwood Partners bought a total of 670,213 shares at weighted average prices ranging from about $17.18 to $18.84 per share, with specific daily averages of $17.5217, $18.1154, and $18.6150.

After these transactions, Broadwood Partners directly owned 16,123,842 shares of STAAR Surgical Common Stock. The filing notes that these securities are directly owned by Broadwood Partners and may be deemed indirectly beneficially owned by Broadwood Capital, Inc., as its general partner, and by Neal C. Bradsher, as President of Broadwood Capital. Each reporting person disclaims beneficial ownership beyond their economic interest. A separate holding entry shows 25,900 shares directly owned by Neal C. Bradsher.

Insights

Equity analyst

Large STAAR Surgical insider group adds 670,213 shares in open-market buys.

Broadwood Partners, L.P., a director-affiliated entity and more-than-10% holder of STAAR Surgical, executed net open-market purchases of 670,213 Common shares over March 11–13. Reported weighted average prices ranged from roughly $17.18 to $18.84 per share.

Following the latest transaction, Broadwood Partners directly held 16,123,842 shares, while a separate line item shows 25,900 shares directly owned by Neal C. Bradsher. No derivative positions remain in the accompanying summary, so the activity reflects straightforward cash purchases rather than option exercises or structured trades.

The footnotes clarify that Broadwood Partners is the direct owner, with Broadwood Capital, Inc. and Neal C. Bradsher potentially having indirect beneficial interests through their roles. Each reporting person disclaims beneficial ownership beyond their pecuniary interest, so interpretation focuses on the entity-level accumulation rather than personal discretionary buying.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		P		54,764	A	$17.5217(2)	15,508,393	D(1)
Common Stock	03/11/2026		P		0	A	$0	15,508,393	I	Footnote(1)
Common Stock	03/12/2026		P		299,432	A	$18.1154(3)	15,807,825	D(1)
Common Stock	03/12/2026		P		0	A	$0	15,807,825	I	Footnote(1)
Common Stock	03/13/2026		P		316,017	A	$18.615(4)	16,123,842	D(1)
Common Stock	03/13/2026		P		0	A	$0	16,123,842	I	Footnote(1)
Common Stock								25,900	D(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BROADWOOD CAPITAL INC

(Last) (First) (Middle)

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Bradsher Neal C

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. ("Broadwood Capital") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

2. This constitutes the weighted average purchase price. The prices range from $17.18 to $17.70. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

3. This constitutes the weighted average purchase price. The prices range from $17.43 to $18.39. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

4. This constitutes the weighted average purchase price. The prices range from $18.10 to $18.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

5. These securities are directly owned by Neal C. Bradsher.

	Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	03/13/2026
	Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	03/13/2026
	Neal C. Bradsher, /s/ Neal C. Bradsher	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many STAAR Surgical (STAA) shares did Broadwood Partners buy in this Form 4?

Broadwood Partners, L.P. reported open-market purchases totaling 670,213 shares of STAAR Surgical Common Stock. These buys occurred across three days, with weighted average prices between roughly $17.18 and $18.84 per share, according to the transaction and footnote disclosures.

What prices did Broadwood Partners pay for STAAR Surgical (STAA) shares?

The filing shows weighted average purchase prices of $17.5217, $18.1154, and $18.6150 per share on different days. Footnotes state the underlying trade prices ranged from $17.18 to $18.84, with full price breakdowns available on request from Broadwood or the issuer.

How many STAAR Surgical (STAA) shares does Broadwood Partners own after these purchases?

After the most recent reported purchase, Broadwood Partners directly owned 16,123,842 shares of STAAR Surgical Common Stock. This figure comes from the post-transaction share balance shown in the latest open-market transaction entry dated March 13 in the Form 4 data.

Who is considered to beneficially own the STAAR Surgical (STAA) shares bought by Broadwood Partners?

The securities are directly owned by Broadwood Partners, L.P.. Footnotes state they may be deemed indirectly beneficially owned by Broadwood Capital, Inc., as general partner, and by Neal C. Bradsher, as its President, though each disclaims beneficial ownership beyond pecuniary interest.

Did STAAR Surgical (STAA) insiders use options or derivatives in these transactions?

No derivative activity is reported in this Form 4. The transactions consist of open-market purchases of Common Stock, and the derivative summary shows zero derivative transactions and zero remaining derivative positions, indicating straightforward share buying rather than option exercises or conversions.

Does Neal C. Bradsher personally hold STAAR Surgical (STAA) shares separate from Broadwood Partners?

Yes. A footnote explains that certain securities are directly owned by Neal C. Bradsher. The transaction table includes a holding entry showing 25,900 shares of STAAR Surgical Common Stock directly owned by him, separate from the much larger position held by Broadwood Partners, L.P.